Olivier Hartmann

9.7k total citations
209 papers, 6.9k citations indexed

About

Olivier Hartmann is a scholar working on Neurology, Oncology and Molecular Biology. According to data from OpenAlex, Olivier Hartmann has authored 209 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Neurology, 47 papers in Oncology and 44 papers in Molecular Biology. Recurrent topics in Olivier Hartmann's work include Neuroblastoma Research and Treatments (96 papers), Cancer therapeutics and mechanisms (32 papers) and Childhood Cancer Survivors' Quality of Life (31 papers). Olivier Hartmann is often cited by papers focused on Neuroblastoma Research and Treatments (96 papers), Cancer therapeutics and mechanisms (32 papers) and Childhood Cancer Survivors' Quality of Life (31 papers). Olivier Hartmann collaborates with scholars based in France, United States and United Kingdom. Olivier Hartmann's co-authors include C Kalifa, Dominique Valteau‐Couanet, E Benhamou, J Lemerle, Gilles Vassal, Jean Michon, Thierry Philip, Catherine Patte, Jean Bénard and Carole Coze and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Olivier Hartmann

206 papers receiving 6.7k citations

Peers

Countries citing papers authored by Olivier Hartmann

Since Specialization

Citations

This map shows the geographic impact of Olivier Hartmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Hartmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Hartmann more than expected).

Fields of papers citing papers by Olivier Hartmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Hartmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Hartmann. The network helps show where Olivier Hartmann may publish in the future.

Co-authorship network of co-authors of Olivier Hartmann

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Hartmann. A scholar is included among the top collaborators of Olivier Hartmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Hartmann. Olivier Hartmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Busulfan–melphalan in high-risk neuroblastoma: the 30-year experience of a single institution 2016 ·Bone Marrow Transplantation ·(unknown), Claudia Pasqualini, Pierre Blanchard, (unknown), E Benhamou, (unknown), Michaëla Semeraro, (unknown), Olivier Hartmann, D Valteau-Couanet	16
2	Les tumeurs malignes de l’ovaire en pédiatrie 2008 ·Archives de Pédiatrie ·Dominique Valteau‐Couanet, (unknown), Christelle Dufour, D. Couanet, Olivier Hartmann, Catherine Patte	4
3	Refuser le traitement : responsabilité et autonomie du patient 2006 ·Bulletin du Cancer ·Daniel Oppenheim, Sarah Dauchy, Olivier Hartmann	1
4	Therapeutic schedules influence the pattern of intellectual decline after irradiation of posterior fossa tumors 2005 ·Pediatric Blood & Cancer ·(unknown), Delphine Viguier, Marie‐Anne Raquin, A. Laurent‐Vannier, Jean‐Louis Habrand, Georges Dellatolas, C Kalifa, Olivier Hartmann, Jacques Grill	46
5	Genetic epidemiology of neuroblastoma: A study of 426 cases at the Institut Gustave‐Roussy in France 2003 ·Pediatric Blood & Cancer ·(unknown), Agnès Chompret, Anne S. Abel, Florent de Vathaire, Marie‐Anne Raquin, Laurence Brugières, Jean Feunteun, Olivier Hartmann, Catherine Bonaïti‐Pellié	27
6	Long‐term risk of second malignant neoplasms after neuroblastoma in childhood: Role of treatment 2003 ·International Journal of Cancer ·Carolé Rubino, Élisabeth Adjadj, Sylvie Guérin, Catherine Guibout, Akhtar Shamsaldin, Marie‐Gabrielle Dondon, Dominique Valteau‐Couanet, Olivier Hartmann, Mike Hawkins, Florent de Vathaire	53
7	Treatment of stage 4s neuroblastoma – report of 10 years' experience of the French Society of Paediatric Oncology (SFOP) 2003 ·British Journal of Cancer ·(unknown), Gudrun Schleiermacher, H Rubie, Olivier Hartmann, Christophe Bergeron, Pascal Chastagner, Françoise Méchinaud, Jean Michon	68
8	Tumeurs cérébrales de l’enfant 1998 ·MTP. Médecine thérapeutique pédiatrie ·C Kalifa, Jacques Grill, C Lévy-Piedbois, Olivier Hartmann, Gilles Vassal	2
9	Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry. 1998 ·Journal of Clinical Oncology ·Ruth Ladenstein, Thierry Philip, Christine Lasset, Olivier Hartmann, Alberto Garaventa, Ross Pinkerton, Jean Michon, Jon Pritchard, Thomas Klingebiel, Bernhard Kremens, Andrew D.J. Pearson, Carole Coze, Paolo Paolucci, Didier Frappaz, Helmut Gadner, Franck Chauvin	127
10	PP5. Teicoplanin or vancomycin in febrile neutropenic children with cancer: A randomized cost effectiveness study 1997 ·European Journal of Cancer ·A. Aupérin, Chiara Capelli, E Benhamou, A. Pinna, Petra H.M. Peeters, (unknown), Olivier Hartmann	2
11	N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique. 1997 ·Journal of Clinical Oncology ·H Rubie, Olivier Hartmann, Jean Michon, Didier Frappaz, Carole Coze, Pascal Chastagner, M.C. Baranzelli, Dominique Plantaz, Hervé Avet‐Loiseau, Jean Bénard, Olivier Delattre, M Favrot, (unknown), Antoine Thyss, Yves Pérel, Christophe Bergeron, (unknown), J.P. Vannier, J Lemerle, D. Sommelet	148
12	Negative 123‐meta‐lodobenzyl‐guanidine imaging in Ewing's sarcoma of bone 1994 ·Medical and Pediatric Oncology ·Odile Oberlin, J. Lumbroso, P. Terrier, Olivier Hartmann, J Lemerle, C Parmentier	2
13	The Lyon and the Ebmt Data On Megatherapy (Mgt) in Neuroblastoma Followed by Bone-Marrow Rescue 1992 ·Bone Marrow Transplantation ·(unknown), Christine Lasset, Olivier Hartmann, (unknown), Guglielmo Dini, J M Zucker, Jean‐Louis Bernard, T. Klingebiel, Ross Pinkerton, (unknown), A D Pearson, T Philip	2
14	Nonmetastatic thoracic neuroblastomas: A review of 40 cases 1991 ·Medical and Pediatric Oncology ·Hervé Rubie, Olivier Hartmann, (unknown), (unknown), (unknown), Laurence Brugières, Dominique Valteau‐Couanet, Alain Robert, Jean Lemerle	12
15	Bone marrow transplantation for neuroblastoma: a review of 509 cases. EBMT Group. 1989 ·PubMed ·Giorgio Dini, T Philip, Olivier Hartmann, Ross Pinkerton, Franck Chauvin, Alberto Garaventa, Edoardo Lanino, Sandro Dallorso	14
16	Stage IV neuroblastoma alive progression free 17 months post-BMT are not cured 1988 ·Bone Marrow Transplantation ·T Philip, Olivier Hartmann, Charles S. August, Guglielmo Dini, F. Beaujean, J M Zucker, Jean‐Louis Bernard, Alberto Garaventa, Christine Lasset, Franck Chauvin, Alida J. Evans	1
17	Therapeutic use of ¹³¹I‐metaiodobenzylguanidine (MIBG) in neuroblastoma: A phase II study in nine patients 1987 ·Medical and Pediatric Oncology ·Olivier Hartmann, J. Lumbroso, J Lemerle, Martin Schlumberger, M. Ricard, Bernard Aubert, (unknown), (unknown), Daniel Olive, L. de Lumley, (unknown)	17
18	Treatment of advanced neuroblastoma with two consecutive high-dose chemotherapy regimens and ABMT. 1985 ·PubMed ·Olivier Hartmann, C Kalifa, F. Beaujean, C Bayle, E Benhamou, J Lemerle	8
19	Néoplasies endocriniennes multiples type 2b. Aspects cliniques, diagnostiques et thérapeutiques. 1984 ·Bulletin du Cancer ·(unknown), P Rougier, J Navarro, Martin Schlumberger, J P Travagli, Bernard Caillou, Olivier Hartmann, J Lemerle, C Parmentier	1
20	ABO BLOOD-GROUPS AND CANCER 1964 ·The Lancet ·Olivier Hartmann, P Stavem	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact